Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.02
+0.02002.00%
Post-market: 1.020.00000.00%19:25 EDT
Volume:3.44M
Turnover:3.53M
Market Cap:345.29M
PE:-4.00
High:1.04
Open:1.04
Low:1.01
Close:1.00
52wk High:2.73
52wk Low:0.9700
Shares:338.52M
Float Shares:327.56M
Volume Ratio:0.51
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-20.86
PE(LYR):-4.51

Loading ...

Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN), Vertex Pharmaceuticals (VRTX) and Solventum Corporation (SOLV)

TIPRANKS
·
May 06

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 06

BUZZ-Ocugen plunges after $115 million convertible bonds offering, bigger loss

Reuters
·
May 06

Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway

TIPRANKS
·
May 05

Ocugen Down Over 19%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Dow Jones
·
May 05

Ocugen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Ocugen reports Q1 EPS (6c), consensus (5c)

TIPRANKS
·
May 05

Gene therapy firm Ocugen's Q1 revenue beats, extends cash runway to 2028

Reuters
·
May 05

Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate

Benzinga Earnings
·
May 05

BRIEF-Ocugen, Inc. Announces Pricing Of $115 Million Of 6.75% Convertible Senior Notes

Reuters
·
May 05

BRIEF-Ocugen Q1 EPS USD -0.06

Reuters
·
May 05

Ocugen Provides Business Update with First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Ocugen prices USD 115 million 6.75% convertible senior notes due 2034

Reuters
·
May 05

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
May 05

Ocugen Announces Private Convertible Notes Offering to Deleverage

TIPRANKS
·
May 05

Ocugen announces private offering of $115M of convertible senior notes

TIPRANKS
·
May 05

Press Release: Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Dow Jones
·
May 05

Ocugen Inc. Stock Advances 4.0%, Outperforms Market

Dow Jones
·
May 02

Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target

TIPRANKS
·
May 01

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Apr 30